Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1996 Nov;224(5):647–664. doi: 10.1097/00000658-199611000-00009

Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

W L Biffl 1, E E Moore 1, F A Moore 1, V M Peterson 1
PMCID: PMC1235442  PMID: 8916880

Abstract

OBJECTIVE: The effects of interleukin (IL)-6 in the injured patient are examined in an attempt to clarify the potential pathophysiologic role of IL-6 in the response to injury. SUMMARY BACKGROUND DATA: Interleukin-6 is an integral cytokine mediator of the acute phase response to injury and infection. However, prolonged and excessive elevations of circulating IL-6 levels in patients after trauma, burns, and elective surgery have been associated with complications and mortality. The mechanistic role of IL-6 in mediating these effects is unclear. METHODS: A review of current literature is performed to summarize the origins, mechanisms of action, and biologic effects of IL-6 and to characterize the IL-6 response to injury. RESULTS: Interleukin-6 is a multifunctional cytokine expressed by a variety of cells after a multitude of stimuli, under complex regulatory control mechanisms. The IL-6 response to injury is uniquely consistent and related to the magnitude of the insult. Moreover, the early postinjury IL-6 response correlates with complications as well as mortality. CONCLUSIONS: Interleukin-6 appears to play an active role in the postinjury immune response, making it an attractive therapeutic target in attempts to control hyperinflammatory provoked organ injury.

Full text

PDF
647

Images in this article

654Figure 2.
on p.654

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarden L. A., De Groot E. R., Schaap O. L., Lansdorp P. M. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 1987 Oct;17(10):1411–1416. doi: 10.1002/eji.1830171004. [DOI] [PubMed] [Google Scholar]
  2. Abraham E., Regan R. F. The effects of hemorrhage and trauma on interleukin 2 production. Arch Surg. 1985 Dec;120(12):1341–1344. doi: 10.1001/archsurg.1985.01390360007002. [DOI] [PubMed] [Google Scholar]
  3. Aderka D., Le J. M., Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol. 1989 Dec 1;143(11):3517–3523. [PubMed] [Google Scholar]
  4. Akira S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., Nakajima T., Hirano T., Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 1990 Jun;9(6):1897–1906. doi: 10.1002/j.1460-2075.1990.tb08316.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Akira S., Nishio Y., Inoue M., Wang X. J., Wei S., Matsusaka T., Yoshida K., Sudo T., Naruto M., Kishimoto T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell. 1994 Apr 8;77(1):63–71. doi: 10.1016/0092-8674(94)90235-6. [DOI] [PubMed] [Google Scholar]
  6. Ala Y., Palluy O., Favero J., Bonne C., Modat G., Dornand J. Hypoxia/reoxygenation stimulates endothelial cells to promote interleukin-1 and interleukin-6 production. Effects of free radical scavengers. Agents Actions. 1992 Sep;37(1-2):134–139. doi: 10.1007/BF01987902. [DOI] [PubMed] [Google Scholar]
  7. Alexander J. W., Ogle C. K., Stinnett J. D., Macmillan B. G. A sequential, prospective analysis of immunologic abnormalities and infection following severe thermal injury. Ann Surg. 1978 Dec;188(6):809–816. doi: 10.1097/00000658-197812000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Amano Y., Lee S. W., Allison A. C. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability. Mol Pharmacol. 1993 Feb;43(2):176–182. [PubMed] [Google Scholar]
  9. Asadullah K., Woiciechowsky C., Döcke W. D., Liebenthal C., Wauer H., Kox W., Volk H. D., Vogel S., Von Baehr R. Immunodepression following neurosurgical procedures. Crit Care Med. 1995 Dec;23(12):1976–1983. doi: 10.1097/00003246-199512000-00006. [DOI] [PubMed] [Google Scholar]
  10. Ayala A., Wang P., Ba Z. F., Perrin M. M., Ertel W., Chaudry I. H. Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol. 1991 Jan;260(1 Pt 2):R167–R171. doi: 10.1152/ajpregu.1991.260.1.R167. [DOI] [PubMed] [Google Scholar]
  11. Baigrie R. J., Lamont P. M., Kwiatkowski D., Dallman M. J., Morris P. J. Systemic cytokine response after major surgery. Br J Surg. 1992 Aug;79(8):757–760. doi: 10.1002/bjs.1800790813. [DOI] [PubMed] [Google Scholar]
  12. Baigrie R. J., Lamont P. M., Whiting S., Morris P. J. Portal endotoxin and cytokine responses during abdominal aortic surgery. Am J Surg. 1993 Sep;166(3):248–251. doi: 10.1016/s0002-9610(05)80967-5. [DOI] [PubMed] [Google Scholar]
  13. Bao S., Goldstone S., Husband A. J. Localization of IFN-gamma and IL-6 mRNA in murine intestine by in situ hybridization. Immunology. 1993 Dec;80(4):666–670. [PMC free article] [PubMed] [Google Scholar]
  14. Barnett C. C., Moore E. E., Moore F. A., Biffl W. L., Smith M. F., Jr, Carl V. S. Intercellular adhesion molecule-1 promotes neutrophil-mediated cytotoxicity. Surgery. 1995 Aug;118(2):171–176. doi: 10.1016/s0039-6060(05)80320-4. [DOI] [PubMed] [Google Scholar]
  15. Baumann H., Prowse K. R., Marinković S., Won K. A., Jahreis G. P. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann N Y Acad Sci. 1989;557:280-95, discussion 295-6. doi: 10.1111/j.1749-6632.1989.tb24021.x. [DOI] [PubMed] [Google Scholar]
  16. Baxevanis C. N., Papilas K., Dedoussis G. V., Pavlis T., Papamichail M. Abnormal cytokine serum levels correlate with impaired cellular immune responses after surgery. Clin Immunol Immunopathol. 1994 Apr;71(1):82–88. doi: 10.1006/clin.1994.1055. [DOI] [PubMed] [Google Scholar]
  17. Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A. 1990 Sep;87(18):6934–6938. doi: 10.1073/pnas.87.18.6934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Beck J. T., Hsu S. M., Wijdenes J., Bataille R., Klein B., Vesole D., Hayden K., Jagannath S., Barlogie B. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med. 1994 Mar 3;330(9):602–605. doi: 10.1056/NEJM199403033300904. [DOI] [PubMed] [Google Scholar]
  19. Biffl W. L., Moore E. E., Moore F. A., Barnett C. C., Jr, Carl V. S., Peterson V. N. Interleukin-6 delays neutrophil apoptosis. Arch Surg. 1996 Jan;131(1):24–30. doi: 10.1001/archsurg.1996.01430130026005. [DOI] [PubMed] [Google Scholar]
  20. Biffl W. L., Moore E. E., Moore F. A., Barnett C. C., Jr, Silliman C. C., Peterson V. M. Interleukin-6 stimulates neutrophil production of platelet-activating factor. J Leukoc Biol. 1996 Apr;59(4):569–574. doi: 10.1002/jlb.59.4.569. [DOI] [PubMed] [Google Scholar]
  21. Biffl W. L., Moore E. E., Moore F. A., Carl V. S., Kim F. J., Franciose R. J. Interleukin-6 potentiates neutrophil priming with platelet-activating factor. Arch Surg. 1994 Nov;129(11):1131–1136. doi: 10.1001/archsurg.1994.01420350029002. [DOI] [PubMed] [Google Scholar]
  22. Billiau A. BSF-2 is not just a differentiation factor. Nature. 1986 Dec 4;324(6096):415–415. doi: 10.1038/324415a0. [DOI] [PubMed] [Google Scholar]
  23. Bitterman H., Kinarty A., Lazarovich H., Lahat N. Acute release of cytokines is proportional to tissue injury induced by surgical trauma and shock in rats. J Clin Immunol. 1991 Jul;11(4):184–192. doi: 10.1007/BF00917424. [DOI] [PubMed] [Google Scholar]
  24. Bjornson A. B., Bjornson H. S., Altemeier W. A. Serum-mediated inhibition of polymorphonuclear leukocyte function following burn injury. Ann Surg. 1981 Nov;194(5):568–575. doi: 10.1097/00000658-198111000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Borish L., Rosenbaum R., Albury L., Clark S. Activation of neutrophils by recombinant interleukin 6. Cell Immunol. 1989 Jul;121(2):280–289. doi: 10.1016/0008-8749(89)90026-9. [DOI] [PubMed] [Google Scholar]
  26. Botha A. J., Moore F. A., Moore E. E., Fontes B., Banerjee A., Peterson V. M. Postinjury neutrophil priming and activation states: therapeutic challenges. Shock. 1995 Mar;3(3):157–166. doi: 10.1097/00024382-199503000-00001. [DOI] [PubMed] [Google Scholar]
  27. Botha A. J., Moore F. A., Moore E. E., Sauaia A., Banerjee A., Peterson V. M. Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J Trauma. 1995 Sep;39(3):411–417. doi: 10.1097/00005373-199509000-00003. [DOI] [PubMed] [Google Scholar]
  28. Bowcock A. M., Kidd J. R., Lathrop G. M., Daneshvar L., May L. T., Ray A., Sehgal P. B., Kidd K. K., Cavalli-Sforza L. L. The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics. 1988 Jul;3(1):8–16. doi: 10.1016/0888-7543(88)90152-8. [DOI] [PubMed] [Google Scholar]
  29. Braquet P., Pignol B., Maisonnet T., Mencia-Huerta J. M. Platelet-activating factor modulates interleukin-6 production by mouse fibroblasts. Int Arch Allergy Appl Immunol. 1991;94(1-4):165–166. doi: 10.1159/000235351. [DOI] [PubMed] [Google Scholar]
  30. Brom J., König W. Cytokine-induced (interleukins-3, -6 and -8 and tumour necrosis factor-beta) activation and deactivation of human neutrophils. Immunology. 1992 Feb;75(2):281–285. [PMC free article] [PubMed] [Google Scholar]
  31. Calandra T., Gerain J., Heumann D., Baumgartner J. D., Glauser M. P. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med. 1991 Jul;91(1):23–29. doi: 10.1016/0002-9343(91)90069-a. [DOI] [PubMed] [Google Scholar]
  32. Caldenhoven E., Coffer P., Yuan J., Van de Stolpe A., Horn F., Kruijer W., Van der Saag P. T. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response element. J Biol Chem. 1994 Aug 19;269(33):21146–21154. [PubMed] [Google Scholar]
  33. Carlos T. M., Harlan J. M. Leukocyte-endothelial adhesion molecules. Blood. 1994 Oct 1;84(7):2068–2101. [PubMed] [Google Scholar]
  34. Casey L. C., Balk R. A., Bone R. C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993 Oct 15;119(8):771–778. doi: 10.7326/0003-4819-119-8-199310150-00001. [DOI] [PubMed] [Google Scholar]
  35. Castell J. V., Gómez-Lechón M. J., David M., Andus T., Geiger T., Trullenque R., Fabra R., Heinrich P. C. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989 Jan 2;242(2):237–239. doi: 10.1016/0014-5793(89)80476-4. [DOI] [PubMed] [Google Scholar]
  36. Chen L., Mory Y., Zilberstein A., Revel M. Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8037–8041. doi: 10.1073/pnas.85.21.8037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Chiu C. P., Moulds C., Coffman R. L., Rennick D., Lee F. Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7099–7103. doi: 10.1073/pnas.85.19.7099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Chrousos G. P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995 May 18;332(20):1351–1362. doi: 10.1056/NEJM199505183322008. [DOI] [PubMed] [Google Scholar]
  39. Cicco N. A., Lindemann A., Content J., Vandenbussche P., Lübbert M., Gauss J., Mertelsmann R., Herrmann F. Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood. 1990 May 15;75(10):2049–2052. [PubMed] [Google Scholar]
  40. Cipolle M. D., Pasquale M. D., Shearer J., Caldwell M., Cerra F. Blunt injury augments interleukin-6 but not tumor necrosis factor in isolated, perfused rat hindlimbs. J Trauma. 1994 Jul;37(1):91–99. doi: 10.1097/00005373-199407000-00016. [DOI] [PubMed] [Google Scholar]
  41. Constantian M. B., Menzoian J. O., Nimberg R. B., Schmid K., Mannick J. A. Association of a circulating immunosuppressive polypeptide with operative and accidental trauma. Ann Surg. 1977 Jan;185(1):73–79. doi: 10.1097/00000658-197701000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Content J., De Wit L., Pierard D., Derynck R., De Clercq E., Fiers W. Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta. Proc Natl Acad Sci U S A. 1982 May;79(9):2768–2772. doi: 10.1073/pnas.79.9.2768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Cromwell O., Hamid Q., Corrigan C. J., Barkans J., Meng Q., Collins P. D., Kay A. B. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology. 1992 Nov;77(3):330–337. [PMC free article] [PubMed] [Google Scholar]
  44. Crozier T. A., Müller J. E., Quittkat D., Sydow M., Wuttke W., Kettler D. Effect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth. 1994 Mar;72(3):280–285. doi: 10.1093/bja/72.3.280. [DOI] [PubMed] [Google Scholar]
  45. Cruickshank A. M., Fraser W. D., Burns H. J., Van Damme J., Shenkin A. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci (Lond) 1990 Aug;79(2):161–165. doi: 10.1042/cs0790161. [DOI] [PubMed] [Google Scholar]
  46. Damas P., Ledoux D., Nys M., Vrindts Y., De Groote D., Franchimont P., Lamy M. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg. 1992 Apr;215(4):356–362. doi: 10.1097/00000658-199204000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Darnell J. E., Jr, Kerr I. M., Stark G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994 Jun 3;264(5164):1415–1421. doi: 10.1126/science.8197455. [DOI] [PubMed] [Google Scholar]
  48. De Benedetti F., Massa M., Pignatti P., Albani S., Novick D., Martini A. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest. 1994 May;93(5):2114–2119. doi: 10.1172/JCI117206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. De Benedetti F., Robbioni P., Massa M., Viola S., Albani S., Martini A. Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. Clin Exp Rheumatol. 1992 Sep-Oct;10(5):493–498. [PubMed] [Google Scholar]
  50. De Caterina R., Libby P., Peng H. B., Thannickal V. J., Rajavashisth T. B., Gimbrone M. A., Jr, Shin W. S., Liao J. K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995 Jul;96(1):60–68. doi: 10.1172/JCI118074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Deitch E. A., Xu D., Franko L., Ayala A., Chaudry I. H. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock. 1994 Feb;1(2):141–145. doi: 10.1097/00024382-199402000-00010. [DOI] [PubMed] [Google Scholar]
  52. Delomenie C., Wautier-Pepin M. P., Chappey O., Wautier J. L. Modulation of human endothelial cell activation by antiproliferative cytokines: exploration of arachidonic acid and intracellular cytokine pathways as possible mechanisms of action. Exp Cell Res. 1993 Jul;207(1):122–130. doi: 10.1006/excr.1993.1170. [DOI] [PubMed] [Google Scholar]
  53. Demling R. H. Adult respiratory distress syndrome: current concepts. New Horiz. 1993 Aug;1(3):388–401. [PubMed] [Google Scholar]
  54. Di Padova F., Pozzi C., Tondre M. J., Tritapepe R. Selective and early increase of IL-1 inhibitors, IL-6 and cortisol after elective surgery. Clin Exp Immunol. 1991 Jul;85(1):137–142. doi: 10.1111/j.1365-2249.1991.tb05694.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Dofferhoff A. S., Bom V. J., de Vries-Hospers H. G., van Ingen J., vd Meer J., Hazenberg B. P., Mulder P. O., Weits J. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med. 1992 Feb;20(2):185–192. doi: 10.1097/00003246-199202000-00007. [DOI] [PubMed] [Google Scholar]
  56. Dougall W. C., Nick H. S. Manganese superoxide dismutase: a hepatic acute phase protein regulated by interleukin-6 and glucocorticoids. Endocrinology. 1991 Nov;129(5):2376–2384. doi: 10.1210/endo-129-5-2376. [DOI] [PubMed] [Google Scholar]
  57. Drost A. C., Burleson D. G., Cioffi W. G., Jr, Mason A. D., Jr, Pruitt B. A., Jr Plasma cytokines after thermal injury and their relationship to infection. Ann Surg. 1993 Jul;218(1):74–78. doi: 10.1097/00000658-199307000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Ertel W., Faist E., Nestle C., Hueltner L., Storck M., Schildberg F. W. Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J Surg Res. 1990 Jun;48(6):622–628. doi: 10.1016/0022-4804(90)90242-t. [DOI] [PubMed] [Google Scholar]
  59. Ertel W., Keel M., Steckholzer U., Ungethüm U., Trentz O. Interleukin-10 attenuates the release of proinflammatory cytokines but depresses splenocyte functions in murine endotoxemia. Arch Surg. 1996 Jan;131(1):51–56. doi: 10.1001/archsurg.1996.01430130053009. [DOI] [PubMed] [Google Scholar]
  60. Faist E., Mewes A., Baker C. C., Strasser T., Alkan S. S., Rieber P., Heberer G. Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma. J Trauma. 1987 Aug;27(8):837–848. doi: 10.1097/00005373-198708000-00001. [DOI] [PubMed] [Google Scholar]
  61. Farhood A., McGuire G. M., Manning A. M., Miyasaka M., Smith C. W., Jaeschke H. Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukoc Biol. 1995 Mar;57(3):368–374. [PubMed] [Google Scholar]
  62. Fassbender K., Pargger H., Müller W., Zimmerli W. Interleukin-6 and acute-phase protein concentrations in surgical intensive care unit patients: diagnostic signs in nosocomial infection. Crit Care Med. 1993 Aug;21(8):1175–1180. doi: 10.1097/00003246-199308000-00017. [DOI] [PubMed] [Google Scholar]
  63. Fattori E., Cappelletti M., Costa P., Sellitto C., Cantoni L., Carelli M., Faggioni R., Fantuzzi G., Ghezzi P., Poli V. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med. 1994 Oct 1;180(4):1243–1250. doi: 10.1084/jem.180.4.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Ferguson-Smith A. C., Chen Y. F., Newman M. S., May L. T., Sehgal P. B., Ruddle F. H. Regional localization of the interferon-beta 2/B-cell stimulatory factor 2/hepatocyte stimulating factor gene to human chromosome 7p15-p21. Genomics. 1988 Apr;2(3):203–208. doi: 10.1016/0888-7543(88)90003-1. [DOI] [PubMed] [Google Scholar]
  65. Finkel M. S., Hoffman R. A., Shen L., Oddis C. V., Simmons R. L., Hattler B. G. Interleukin-6 (IL-6) as a mediator of stunned myocardium. Am J Cardiol. 1993 May 15;71(13):1231–1232. doi: 10.1016/0002-9149(93)90654-u. [DOI] [PubMed] [Google Scholar]
  66. Fiorillo M. T., Toniatti C., Van Snick J., Ciliberto G. Expression of the murine interleukin 6 receptor in hepatoma cells: the intracytoplasmic domain is not required for interleukin 6 signal transduction. Eur J Immunol. 1992 Mar;22(3):799–804. doi: 10.1002/eji.1830220325. [DOI] [PubMed] [Google Scholar]
  67. Frei K., Leist T. P., Meager A., Gallo P., Leppert D., Zinkernagel R. M., Fontana A. Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med. 1988 Jul 1;168(1):449–453. doi: 10.1084/jem.168.1.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Frei K., Malipiero U. V., Leist T. P., Zinkernagel R. M., Schwab M. E., Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol. 1989 Apr;19(4):689–694. doi: 10.1002/eji.1830190418. [DOI] [PubMed] [Google Scholar]
  69. Friese R. S., Rehring T. F., Wollmering M., Moore E. E., Ketch L. L., Banerjee A., Harken A. H. Trauma primes cells. Shock. 1994 May;1(5):388–394. doi: 10.1097/00024382-199405000-00013. [DOI] [PubMed] [Google Scholar]
  70. Fujita H., Morita I., Murota S. Involvement of adhesion molecules (CD11a-ICAM-1) in vascular endothelial cell injury elicited by PMA-stimulated neutrophils. Biochem Biophys Res Commun. 1991 Jun 14;177(2):664–672. doi: 10.1016/0006-291x(91)91840-9. [DOI] [PubMed] [Google Scholar]
  71. Gauldie J., Richards C., Harnish D., Lansdorp P., Baumann H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7251–7255. doi: 10.1073/pnas.84.20.7251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Gearing D. P., Thut C. J., VandeBos T., Gimpel S. D., Delaney P. B., King J., Price V., Cosman D., Beckmann M. P. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 1991 Oct;10(10):2839–2848. doi: 10.1002/j.1460-2075.1991.tb07833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Gelfand J. A., Donelan M., Burke J. F. Preferential activation and depletion of the alternative complement pathway by burn injury. Ann Surg. 1983 Jul;198(1):58–62. doi: 10.1097/00000658-198307000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Gennari R., Alexander J. W. Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time-dependent manner by enhancing host defense. Crit Care Med. 1995 Dec;23(12):1945–1953. doi: 10.1097/00003246-199512000-00002. [DOI] [PubMed] [Google Scholar]
  75. Gennari R., Alexander J. W., Pyles T., Hartmann S., Ogle C. K. Effects of antimurine interleukin-6 on bacterial translocation during gut-derived sepsis. Arch Surg. 1994 Nov;129(11):1191–1197. doi: 10.1001/archsurg.1994.01420350089012. [DOI] [PubMed] [Google Scholar]
  76. Gibbons R., Martinez O., Matli M., Heinzel F., Bernstein M., Warren R. Recombinant IL-4 inhibits IL-6 synthesis by adherent peripheral blood cells in vitro. Lymphokine Res. 1990 Fall;9(3):283–293. [PubMed] [Google Scholar]
  77. Glaser F., Sannwald G. A., Buhr H. J., Kuntz C., Mayer H., Klee F., Herfarth C. General stress response to conventional and laparoscopic cholecystectomy. Ann Surg. 1995 Apr;221(4):372–380. doi: 10.1097/00000658-199504000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Goldie A. S., Fearon K. C., Ross J. A., Barclay G. R., Jackson R. E., Grant I. S., Ramsay G., Blyth A. S., Howie J. C. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA. 1995 Jul 12;274(2):172–177. [PubMed] [Google Scholar]
  79. Goss J. A., Mangino M. J., Flye M. W. Prostaglandin E2 production during hepatic regeneration downregulates Kupffer cell IL-6 production. Ann Surg. 1992 Jun;215(6):553–560. [PMC free article] [PubMed] [Google Scholar]
  80. Gross V., Villiger P. M., Zhang B., Lotz M. Retinoic acid inhibits interleukin-1-induced cytokine synthesis in human monocytes. J Leukoc Biol. 1993 Aug;54(2):125–132. doi: 10.1002/jlb.54.2.125. [DOI] [PubMed] [Google Scholar]
  81. Gross V., Zhang B., Geng Y., Villiger P. M., Lotz M. Regulation of interleukin-6 (IL-6) expression: evidence for a tissue-specific role of protein kinase C. J Clin Immunol. 1993 Sep;13(5):310–320. doi: 10.1007/BF00920239. [DOI] [PubMed] [Google Scholar]
  82. Guerne P. A., Zuraw B. L., Vaughan J. H., Carson D. A., Lotz M. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest. 1989 Feb;83(2):585–592. doi: 10.1172/JCI113921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Guo Y., Dickerson C., Chrest F. J., Adler W. H., Munster A. M., Winchurch R. A. Increased levels of circulating interleukin 6 in burn patients. Clin Immunol Immunopathol. 1990 Mar;54(3):361–371. doi: 10.1016/0090-1229(90)90050-z. [DOI] [PubMed] [Google Scholar]
  84. Gutierrez S., Palacios I., Egido J., Zarco P., Miguelez R., González E., Herrero-Beaumont G. IL-1 beta and IL-6 stimulate the production of platelet-activating factor (PAF) by cultured rabbit synovial cells. Clin Exp Immunol. 1995 Mar;99(3):364–368. doi: 10.1111/j.1365-2249.1995.tb05559.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Hack C. E., De Groot E. R., Felt-Bersma R. J., Nuijens J. H., Strack Van Schijndel R. J., Eerenberg-Belmer A. J., Thijs L. G., Aarden L. A. Increased plasma levels of interleukin-6 in sepsis. Blood. 1989 Oct;74(5):1704–1710. [PubMed] [Google Scholar]
  86. Haegeman G., Content J., Volckaert G., Derynck R., Tavernier J., Fiers W. Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem. 1986 Sep 15;159(3):625–632. doi: 10.1111/j.1432-1033.1986.tb09931.x. [DOI] [PubMed] [Google Scholar]
  87. Hakim A. A. An immunosuppressive factor from serum of thermally traumatized patients. J Trauma. 1977 Dec;17(12):908–919. doi: 10.1097/00005373-197712000-00004. [DOI] [PubMed] [Google Scholar]
  88. Heddle N. M., Klama L., Singer J., Richards C., Fedak P., Walker I., Kelton J. G. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med. 1994 Sep 8;331(10):625–628. doi: 10.1056/NEJM199409083311001. [DOI] [PubMed] [Google Scholar]
  89. Hedges S., Svensson M., Svanborg C. Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun. 1992 Apr;60(4):1295–1301. doi: 10.1128/iai.60.4.1295-1301.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Heideman M., Kaijser B., Gelin L. E. Complement activation and hematologic, hemodynamic, and respiratory reactions early after soft-tissue injury. J Trauma. 1978 Oct;18(10):696–700. doi: 10.1097/00005373-197810000-00002. [DOI] [PubMed] [Google Scholar]
  91. Heinrich P. C., Castell J. V., Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990 Feb 1;265(3):621–636. doi: 10.1042/bj2650621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Helfgott D. C., Tatter S. B., Santhanam U., Clarick R. H., Bhardwaj N., May L. T., Sehgal P. B. Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol. 1989 Feb 1;142(3):948–953. [PubMed] [Google Scholar]
  93. Helle M., Brakenhoff J. P., De Groot E. R., Aarden L. A. Interleukin 6 is involved in interleukin 1-induced activities. Eur J Immunol. 1988 Jun;18(6):957–959. doi: 10.1002/eji.1830180619. [DOI] [PubMed] [Google Scholar]
  94. Henschler R., Lindemann A., Brach M. A., Mackensen A., Mertelsmann R. H., Herrmann F. Expression of functional receptors for interleukin-6 by human polymorphonuclear leukocytes. Downregulation by granulocyte-macrophage colony-stimulating factor. FEBS Lett. 1991 May 20;283(1):47–51. doi: 10.1016/0014-5793(91)80550-m. [DOI] [PubMed] [Google Scholar]
  95. Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 1990 Dec 21;63(6):1149–1157. doi: 10.1016/0092-8674(90)90411-7. [DOI] [PubMed] [Google Scholar]
  96. Hill J., Lindsay T., Rusche J., Valeri C. R., Shepro D., Hechtman H. B. A Mac-1 antibody reduces liver and lung injury but not neutrophil sequestration after intestinal ischemia-reperfusion. Surgery. 1992 Aug;112(2):166–172. [PubMed] [Google Scholar]
  97. Hirano T., Taga T., Nakano N., Yasukawa K., Kashiwamura S., Shimizu K., Nakajima K., Pyun K. H., Kishimoto T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci U S A. 1985 Aug;82(16):5490–5494. doi: 10.1073/pnas.82.16.5490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Hirano T., Taga T., Yasukawa K., Nakajima K., Nakano N., Takatsuki F., Shimizu M., Murashima A., Tsunasawa S., Sakiyama F. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci U S A. 1987 Jan;84(1):228–231. doi: 10.1073/pnas.84.1.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 1986 Nov 6;324(6092):73–76. doi: 10.1038/324073a0. [DOI] [PubMed] [Google Scholar]
  100. Hoch R. C., Rodriguez R., Manning T., Bishop M., Mead P., Shoemaker W. C., Abraham E. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med. 1993 Jun;21(6):839–845. doi: 10.1097/00003246-199306000-00010. [DOI] [PubMed] [Google Scholar]
  101. Hooghe-Peters E., Velkeniers B., Vanhaelst L., Hooghe R. Interleukin-1, interleukin-6: messengers in the neuroendocrine immune system? Pathol Res Pract. 1991 Jun;187(5):622–625. doi: 10.1016/S0344-0338(11)80158-5. [DOI] [PubMed] [Google Scholar]
  102. Horii Y., Muraguchi A., Iwano M., Matsuda T., Hirayama T., Yamada H., Fujii Y., Dohi K., Ishikawa H., Ohmoto Y. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol. 1989 Dec 15;143(12):3949–3955. [PubMed] [Google Scholar]
  103. Houssiau F. A., Bukasa K., Sindic C. J., Van Damme J., Van Snick J. Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol. 1988 Feb;71(2):320–323. [PMC free article] [PubMed] [Google Scholar]
  104. Ihle J. N., Witthuhn B. A., Quelle F. W., Yamamoto K., Thierfelder W. E., Kreider B., Silvennoinen O. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci. 1994 May;19(5):222–227. doi: 10.1016/0968-0004(94)90026-4. [DOI] [PubMed] [Google Scholar]
  105. Jilka R. L., Hangoc G., Girasole G., Passeri G., Williams D. C., Abrams J. S., Boyce B., Broxmeyer H., Manolagas S. C. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992 Jul 3;257(5066):88–91. doi: 10.1126/science.1621100. [DOI] [PubMed] [Google Scholar]
  106. Jones S. C., Trejdosiewicz L. K., Banks R. E., Howdle P. D., Axon A. T., Dixon M. F., Whicher J. T. Expression of interleukin-6 by intestinal enterocytes. J Clin Pathol. 1993 Dec;46(12):1097–1100. doi: 10.1136/jcp.46.12.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Joris J., Cigarini I., Legrand M., Jacquet N., De Groote D., Franchimont P., Lamy M. Metabolic and respiratory changes after cholecystectomy performed via laparotomy or laparoscopy. Br J Anaesth. 1992 Oct;69(4):341–345. doi: 10.1093/bja/69.4.341. [DOI] [PubMed] [Google Scholar]
  108. Kawamura T., Wakusawa R., Okada K., Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth. 1993 Nov;40(11):1016–1021. doi: 10.1007/BF03009470. [DOI] [PubMed] [Google Scholar]
  109. Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 1988 Mar 3;332(6159):83–85. doi: 10.1038/332083a0. [DOI] [PubMed] [Google Scholar]
  110. Kharazmi A., Nielsen H., Rechnitzer C., Bendtzen K. Interleukin 6 primes human neutrophil and monocyte oxidative burst response. Immunol Lett. 1989 May;21(2):177–184. doi: 10.1016/0165-2478(89)90056-4. [DOI] [PubMed] [Google Scholar]
  111. Kim C., Schinkel C., Fuchs D., Stadler J., Walz A., Zedler S., von Donnersmarck G. H., Faist E. Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress. Arch Surg. 1995 Dec;130(12):1330–1336. doi: 10.1001/archsurg.1995.01430120084013. [DOI] [PubMed] [Google Scholar]
  112. Kishimoto T., Akira S., Taga T. IL-6 receptor and mechanism of signal transduction. Int J Immunopharmacol. 1992 Apr;14(3):431–438. doi: 10.1016/0192-0561(92)90173-i. [DOI] [PubMed] [Google Scholar]
  113. Kishimoto T., Akira S., Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 1992 Oct 23;258(5082):593–597. doi: 10.1126/science.1411569. [DOI] [PubMed] [Google Scholar]
  114. Kishimoto T., Hirano T. Molecular regulation of B lymphocyte response. Annu Rev Immunol. 1988;6:485–512. doi: 10.1146/annurev.iy.06.040188.002413. [DOI] [PubMed] [Google Scholar]
  115. Kita Y., Iwaki Y., Demetris A. J., Starzl T. E. Evaluation of sequential serum interleukin-6 levels in liver allograft recipients. Transplantation. 1994 Apr 15;57(7):1037–1041. doi: 10.1097/00007890-199404150-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Kloosterman T., von Blomberg B. M., Borgstein P., Cuesta M. A., Scheper R. J., Meijer S. Unimpaired immune functions after laparoscopic cholecystectomy. Surgery. 1994 Apr;115(4):424–428. [PubMed] [Google Scholar]
  117. Koike K., Moore E. E., Moore F. A., Franciose R. J., Fontes B., Kim F. J. CD11b blockade prevents lung injury despite neutrophil priming after gut ischemia/reperfusion. J Trauma. 1995 Jul;39(1):23–28. doi: 10.1097/00005373-199507000-00003. [DOI] [PubMed] [Google Scholar]
  118. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Köhler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 1994 Mar 24;368(6469):339–342. doi: 10.1038/368339a0. [DOI] [PubMed] [Google Scholar]
  119. Kossmann T., Hans V. H., Imhof H. G., Stocker R., Grob P., Trentz O., Morganti-Kossmann C. Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock. 1995 Nov;4(5):311–317. doi: 10.1097/00024382-199511000-00001. [DOI] [PubMed] [Google Scholar]
  120. Kowal-Vern A., Walenga J. M., Hoppensteadt D., Sharp-Pucci M., Gamelli R. L. Interleukin-2 and interleukin-6 in relation to burn wound size in the acute phase of thermal injury. J Am Coll Surg. 1994 Apr;178(4):357–362. [PubMed] [Google Scholar]
  121. Kukielka G. L., Youker K. A., Hawkins H. K., Perrard J. L., Michael L. H., Ballantyne C. M., Smith C. W., Entman M. L. Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusion. Ann N Y Acad Sci. 1994 Jun 17;723:258–270. [PubMed] [Google Scholar]
  122. Kupper T. S., Min K., Sehgal P., Mizutani H., Birchall N., Ray A., May L. Production of IL-6 by keratinocytes. Implications for epidermal inflammation and immunity. Ann N Y Acad Sci. 1989;557:454–465. [PubMed] [Google Scholar]
  123. Le J. M., Vilcek J. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest. 1989 Dec;61(6):588–602. [PubMed] [Google Scholar]
  124. Leal-Berumen I., Conlon P., Marshall J. S. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J Immunol. 1994 Jun 1;152(11):5468–5476. [PubMed] [Google Scholar]
  125. Leeuwenberg J. F., von Asmuth E. J., Jeunhomme T. M., Buurman W. A. IFN-gamma regulates the expression of the adhesion molecule ELAM-1 and IL-6 production by human endothelial cells in vitro. J Immunol. 1990 Oct 1;145(7):2110–2114. [PubMed] [Google Scholar]
  126. Libert C., Van Bladel S., Brouckaert P., Fiers W. The influence of modulating substances on tumor necrosis factor and interleukin-6 levels after injection of murine tumor necrosis factor or lipopolysaccharide in mice. J Immunother (1991) 1991 Aug;10(4):227–235. doi: 10.1097/00002371-199108000-00001. [DOI] [PubMed] [Google Scholar]
  127. Libert C., Vink A., Coulie P., Brouckaert P., Everaerdt B., Van Snick J., Fiers W. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models. Eur J Immunol. 1992 Oct;22(10):2625–2630. doi: 10.1002/eji.1830221023. [DOI] [PubMed] [Google Scholar]
  128. Lotz M. Interleukin-6. Cancer Invest. 1993;11(6):732–742. doi: 10.3109/07357909309046948. [DOI] [PubMed] [Google Scholar]
  129. Lotz M., Jirik F., Kabouridis P., Tsoukas C., Hirano T., Kishimoto T., Carson D. A. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med. 1988 Mar 1;167(3):1253–1258. doi: 10.1084/jem.167.3.1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Lütticken C., Wegenka U. M., Yuan J., Buschmann J., Schindler C., Ziemiecki A., Harpur A. G., Wilks A. F., Yasukawa K., Taga T. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science. 1994 Jan 7;263(5143):89–92. doi: 10.1126/science.8272872. [DOI] [PubMed] [Google Scholar]
  131. Maruo N., Morita I., Shirao M., Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology. 1992 Aug;131(2):710–714. doi: 10.1210/endo.131.2.1639018. [DOI] [PubMed] [Google Scholar]
  132. Matsuda T., Hirano T., Kishimoto T. Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies. Eur J Immunol. 1988 Jun;18(6):951–956. doi: 10.1002/eji.1830180618. [DOI] [PubMed] [Google Scholar]
  133. Matsuda T., Hirano T., Nagasawa S., Kishimoto T. Identification of alpha 2-macroglobulin as a carrier protein for IL-6. J Immunol. 1989 Jan 1;142(1):148–152. [PubMed] [Google Scholar]
  134. May L. T., Ghrayeb J., Santhanam U., Tatter S. B., Sthoeger Z., Helfgott D. C., Chiorazzi N., Grieninger G., Sehgal P. B. Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. J Biol Chem. 1988 Jun 5;263(16):7760–7766. [PubMed] [Google Scholar]
  135. May L. T., Santhanam U., Tatter S. B., Ghrayeb J., Sehgal P. B. Multiple forms of human interleukin-6. Phosphoglycoproteins secreted by many different tissues. Ann N Y Acad Sci. 1989;557:114–121. [PubMed] [Google Scholar]
  136. May L. T., Viguet H., Kenney J. S., Ida N., Allison A. C., Sehgal P. B. High levels of "complexed" interleukin-6 in human blood. J Biol Chem. 1992 Sep 25;267(27):19698–19704. [PubMed] [Google Scholar]
  137. McCurry K. R., Campbell D. A., Jr, Scales W. E., Warren J. S., Remick D. G. Tumor necrosis factor, interleukin 6, and the acute phase response following hepatic ischemia/reperfusion. J Surg Res. 1993 Jul;55(1):49–54. doi: 10.1006/jsre.1993.1107. [DOI] [PubMed] [Google Scholar]
  138. McGee D. W., Beagley K. W., Aicher W. K., McGhee J. R. Transforming growth factor-beta enhances interleukin-6 secretion by intestinal epithelial cells. Immunology. 1992 Sep;77(1):7–12. [PMC free article] [PubMed] [Google Scholar]
  139. McMillen M. A., Sumpio B. E. Endothelins: polyfunctional cytokines. J Am Coll Surg. 1995 May;180(5):621–637. [PubMed] [Google Scholar]
  140. Meade P., Shoemaker W. C., Donnelly T. J., Abraham E., Jagels M. A., Cryer H. G., Hugli T. E., Bishop M. H., Wo C. C. Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury. J Trauma. 1994 May;36(5):651–657. doi: 10.1097/00005373-199405000-00009. [DOI] [PubMed] [Google Scholar]
  141. Meduri G. U., Headley S., Kohler G., Stentz F., Tolley E., Umberger R., Leeper K. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest. 1995 Apr;107(4):1062–1073. doi: 10.1378/chest.107.4.1062. [DOI] [PubMed] [Google Scholar]
  142. Meduri G. U., Kohler G., Headley S., Tolley E., Stentz F., Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 1995 Nov;108(5):1303–1314. doi: 10.1378/chest.108.5.1303. [DOI] [PubMed] [Google Scholar]
  143. Melani C., Mattia G. F., Silvani A., Carè A., Rivoltini L., Parmiani G., Colombo M. P. Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytes. Blood. 1993 May 15;81(10):2744–2749. [PubMed] [Google Scholar]
  144. Meldrum D. R., Ayala A., Wang P., Ertel W., Chaudry I. H. Association between decreased splenic ATP levels and immunodepression: amelioration with ATP-MgCl2. Am J Physiol. 1991 Aug;261(2 Pt 2):R351–R357. doi: 10.1152/ajpregu.1991.261.2.R351. [DOI] [PubMed] [Google Scholar]
  145. Meyer T. A., Noguchi Y., Ogle C. K., Tiao G., Wang J. J., Fischer J. E., Hasselgren P. O. Endotoxin stimulates interleukin-6 production in intestinal epithelial cells. A synergistic effect with prostaglandin E2. Arch Surg. 1994 Dec;129(12):1290–1295. doi: 10.1001/archsurg.1994.01420360080010. [DOI] [PubMed] [Google Scholar]
  146. Miyaura C., Onozaki K., Akiyama Y., Taniyama T., Hirano T., Kishimoto T., Suda T. Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1). FEBS Lett. 1988 Jul 4;234(1):17–21. doi: 10.1016/0014-5793(88)81293-6. [DOI] [PubMed] [Google Scholar]
  147. Moore C. M., Desborough J. P., Powell H., Burrin J. M., Hall G. M. Effects of extradural anaesthesia on interleukin-6 and acute phase response to surgery. Br J Anaesth. 1994 Mar;72(3):272–279. doi: 10.1093/bja/72.3.272. [DOI] [PubMed] [Google Scholar]
  148. Moore E. E., Moore F. A., Franciose R. J., Kim F. J., Biffl W. L., Banerjee A. The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma. 1994 Dec;37(6):881–887. doi: 10.1097/00005373-199412000-00002. [DOI] [PubMed] [Google Scholar]
  149. Moore F. A., Moore E. E., Poggetti R., McAnena O. J., Peterson V. M., Abernathy C. M., Parsons P. E. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma. 1991 May;31(5):629–638. doi: 10.1097/00005373-199105000-00006. [DOI] [PubMed] [Google Scholar]
  150. Moore F. A., Peterson V. M., Moore E. E., Rundus C., Poggetti R. Inadequate granulopoiesis after major torso trauma: a hematopoietic regulatory paradox. Surgery. 1990 Oct;108(4):667–675. [PubMed] [Google Scholar]
  151. Moscovitz H., Shofer F., Mignott H., Behrman A., Kilpatrick L. Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit Care Med. 1994 Jul;22(7):1102–1107. doi: 10.1097/00003246-199407000-00009. [DOI] [PubMed] [Google Scholar]
  152. Mullen P. G., Windsor A. C., Walsh C. J., Fowler A. A., 3rd, Sugerman H. J. Tumor necrosis factor-alpha and interleukin-6 selectively regulate neutrophil function in vitro. J Surg Res. 1995 Feb;58(2):124–130. doi: 10.1006/jsre.1995.1020. [DOI] [PubMed] [Google Scholar]
  153. Munster A. M., Hoagland H. C., Pruitt B. A., Jr The effect of thermal injury on serum immunoglobulins. Ann Surg. 1970 Dec;172(6):965–969. doi: 10.1097/00000658-197012000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Munster A. M. Post-traumatic immunosuppression is due to activation of suppressor T cells. Lancet. 1976 Jun 19;1(7973):1329–1330. doi: 10.1016/s0140-6736(76)92658-1. [DOI] [PubMed] [Google Scholar]
  155. Munster A. M., Winchurch R. A., Birmingham W. J., Keeling P. Longitudinal assay of lymphocyte responsiveness in patients with major burns. Ann Surg. 1980 Dec;192(6):772–775. doi: 10.1097/00000658-198012000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science. 1993 Jun 18;260(5115):1808–1810. doi: 10.1126/science.8511589. [DOI] [PubMed] [Google Scholar]
  157. Murakami M., Narazaki M., Hibi M., Yawata H., Yasukawa K., Hamaguchi M., Taga T., Kishimoto T. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11349–11353. doi: 10.1073/pnas.88.24.11349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Müllberg J., Dittrich E., Graeve L., Gerhartz C., Yasukawa K., Taga T., Kishimoto T., Heinrich P. C., Rose-John S. Differential shedding of the two subunits of the interleukin-6 receptor. FEBS Lett. 1993 Oct 11;332(1-2):174–178. doi: 10.1016/0014-5793(93)80507-q. [DOI] [PubMed] [Google Scholar]
  159. Naitoh Y., Fukata J., Tominaga T., Nakai Y., Tamai S., Mori K., Imura H. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun. 1988 Sep 30;155(3):1459–1463. doi: 10.1016/s0006-291x(88)81305-6. [DOI] [PubMed] [Google Scholar]
  160. Nakajima K., Martínez-Maza O., Hirano T., Breen E. C., Nishanian P. G., Salazar-Gonzalez J. F., Fahey J. L., Kishimoto T. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol. 1989 Jan 15;142(2):531–536. [PubMed] [Google Scholar]
  161. Nesbitt J. E., Fuller G. M. Differential regulation of interleukin-6 receptor and gp130 gene expression in rat hepatocytes. Mol Biol Cell. 1992 Jan;3(1):103–112. doi: 10.1091/mbc.3.1.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Nijsten M. W., Hack C. E., Helle M., ten Duis H. J., Klasen H. J., Aarden L. A. Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery. 1991 Jun;109(6):761–767. [PubMed] [Google Scholar]
  163. Nishimoto N., Yoshizaki K., Tagoh H., Monden M., Kishimoto S., Hirano T., Kishimoto T. Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol. 1989 Mar;50(3):399–401. doi: 10.1016/0090-1229(89)90147-5. [DOI] [PubMed] [Google Scholar]
  164. O'Gorman R. B., Feliciano D. V., Matthews K. S., Matthews R., Bitondo C. G., Mattox K. L., Jordan G. L., Jr Correlation of immunologic and nutritional status with infectious complications after major abdominal trauma. Surgery. 1986 May;99(5):549–556. [PubMed] [Google Scholar]
  165. Ohzato H., Yoshizaki K., Nishimoto N., Ogata A., Tagoh H., Monden M., Gotoh M., Kishimoto T., Mori T. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery. 1992 Feb;111(2):201–209. [PubMed] [Google Scholar]
  166. Oka Y., Murata A., Nishijima J., Yasuda T., Hiraoka N., Ohmachi Y., Yasuda T., Kitagawa K., Toda H., Tanaka N. Enhanced attachment and elastase-releasing capacity of neutrophils after surgery. Am J Surg. 1994 Apr;167(4):405–411. doi: 10.1016/0002-9610(94)90125-2. [DOI] [PubMed] [Google Scholar]
  167. Oldenburg H. S., Rogy M. A., Lazarus D. D., Van Zee K. J., Keeler B. P., Chizzonite R. A., Lowry S. F., Moldawer L. L. Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6. Eur J Immunol. 1993 Aug;23(8):1889–1894. doi: 10.1002/eji.1830230824. [DOI] [PubMed] [Google Scholar]
  168. Ono M., Kohda H., Kawaguchi T., Ohhira M., Sekiya C., Namiki M., Takeyasu A., Taniguchi N. Induction of Mn-superoxide dismutase by tumor necrosis factor, interleukin-1 and interleukin-6 in human hepatoma cells. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1100–1107. doi: 10.1016/0006-291x(92)91845-h. [DOI] [PubMed] [Google Scholar]
  169. Parry-Billings M., Baigrie R. J., Lamont P. M., Morris P. J., Newsholme E. A. Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg. 1992 Oct;127(10):1237–1240. doi: 10.1001/archsurg.1992.01420100099017. [DOI] [PubMed] [Google Scholar]
  170. Plaut M., Pierce J. H., Watson C. J., Hanley-Hyde J., Nordan R. P., Paul W. E. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature. 1989 May 4;339(6219):64–67. doi: 10.1038/339064a0. [DOI] [PubMed] [Google Scholar]
  171. Poupart P., De Wit L., Content J. Induction and regulation of the 26-kDa protein in the absence of synthesis of beta-interferon mRNA in human cells. Eur J Biochem. 1984 Aug 15;143(1):15–21. doi: 10.1111/j.1432-1033.1984.tb08332.x. [DOI] [PubMed] [Google Scholar]
  172. Poupart P., Vandenabeele P., Cayphas S., Van Snick J., Haegeman G., Kruys V., Fiers W., Content J. B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF). EMBO J. 1987 May;6(5):1219–1224. doi: 10.1002/j.1460-2075.1987.tb02357.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Pullicino E. A., Carli F., Poole S., Rafferty B., Malik S. T., Elia M. The relationship between the circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Lymphokine Res. 1990 Summer;9(2):231–238. [PubMed] [Google Scholar]
  174. Rahman S., Bunning R. A., Dobson P. R., Evans D. B., Chapman K., Jones T. H., Brown B. L., Russell R. G. Bradykinin stimulates the production of prostaglandin E2 and interleukin-6 in human osteoblast-like cells. Biochim Biophys Acta. 1992 Apr 30;1135(1):97–102. doi: 10.1016/0167-4889(92)90172-8. [DOI] [PubMed] [Google Scholar]
  175. Ray A., Tatter S. B., Santhanam U., Helfgott D. C., May L. T., Sehgal P. B. Regulation of expression of interleukin-6. Molecular and clinical studies. Ann N Y Acad Sci. 1989;557:353–362. [PubMed] [Google Scholar]
  176. Redmond H. P., Watson R. W., Houghton T., Condron C., Watson R. G., Bouchier-Hayes D. Immune function in patients undergoing open vs laparoscopic cholecystectomy. Arch Surg. 1994 Dec;129(12):1240–1246. doi: 10.1001/archsurg.1994.01420360030003. [DOI] [PubMed] [Google Scholar]
  177. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med. 1993 Oct 21;329(17):1246–1253. doi: 10.1056/NEJM199310213291708. [DOI] [PubMed] [Google Scholar]
  178. Ritchie D. G., Fuller G. M. Hepatocyte-stimulating factor: a monocyte-derived acute-phase regulatory protein. Ann N Y Acad Sci. 1983 Jun 27;408:490–502. doi: 10.1111/j.1749-6632.1983.tb23268.x. [DOI] [PubMed] [Google Scholar]
  179. Rodriguez J. L., Miller C. G., Garner W. L., Till G. O., Guerrero P., Moore N. P., Corridore M., Normolle D. P., Smith D. J., Remick D. G. Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma. 1993 May;34(5):684–695. doi: 10.1097/00005373-199305000-00011. [DOI] [PubMed] [Google Scholar]
  180. Rose-John S., Schooltink H., Schmitz-Van de Leur H., Müllberg J., Heinrich P. C., Graeve L. Intracellular retention of interleukin-6 abrogates signaling. J Biol Chem. 1993 Oct 15;268(29):22084–22091. [PubMed] [Google Scholar]
  181. Roumen R. M., Hendriks T., van der Ven-Jongekrijg J., Nieuwenhuijzen G. A., Sauerwein R. W., van der Meer J. W., Goris R. J. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg. 1993 Dec;218(6):769–776. doi: 10.1097/00000658-199312000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Sachs L., Lotem J., Shabo Y. The molecular regulators of macrophage and granulocyte development. Role of MGI-2/IL-6. Ann N Y Acad Sci. 1989;557:417-35, discussion 435-7. doi: 10.1111/j.1749-6632.1989.tb24035.x. [DOI] [PubMed] [Google Scholar]
  183. Saito M., Yoshida K., Hibi M., Taga T., Kishimoto T. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J Immunol. 1992 Jun 15;148(12):4066–4071. [PubMed] [Google Scholar]
  184. Santhanam U., Ghrayeb J., Sehgal P. B., May L. T. Post-translational modifications of human interleukin-6. Arch Biochem Biophys. 1989 Oct;274(1):161–170. doi: 10.1016/0003-9861(89)90427-x. [DOI] [PubMed] [Google Scholar]
  185. Sarantos P., Abouhamze A., Abcouwer S., Chakrabarti R., Copeland E. M., Souba W. W. Cytokines decrease glutaminase expression in human fibroblasts. Surgery. 1994 Aug;116(2):276–284. [PubMed] [Google Scholar]
  186. Satoh T., Nakamura S., Taga T., Matsuda T., Hirano T., Kishimoto T., Kaziro Y. Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6. Mol Cell Biol. 1988 Aug;8(8):3546–3549. doi: 10.1128/mcb.8.8.3546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S. C., Dinarello C. A. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 1990 Jan 1;75(1):40–47. [PubMed] [Google Scholar]
  188. Schlüter B., König B., Bergmann U., Müller F. E., König W. Interleukin 6--a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells. J Trauma. 1991 Dec;31(12):1663–1670. doi: 10.1097/00005373-199112000-00017. [DOI] [PubMed] [Google Scholar]
  189. Schmand J. F., Ayala A., Chaudry I. H. Effects of trauma, duration of hypotension, and resuscitation regimen on cellular immunity after hemorrhagic shock. Crit Care Med. 1994 Jul;22(7):1076–1083. doi: 10.1097/00003246-199407000-00005. [DOI] [PubMed] [Google Scholar]
  190. Schmand J. F., Ayala A., Morrison M. H., Chaudry I. H. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: restoration of macrophage integrity and prevention of increased circulating interleukin-6 levels. Crit Care Med. 1995 May;23(5):806–814. doi: 10.1097/00003246-199505000-00006. [DOI] [PubMed] [Google Scholar]
  191. Schooltink H., Schmitz-Van de Leur H., Heinrich P. C., Rose-John S. Up-regulation of the interleukin-6-signal transducing protein (gp130) by interleukin-6 and dexamethasone in HepG2 cells. FEBS Lett. 1992 Feb 10;297(3):263–265. doi: 10.1016/0014-5793(92)80552-r. [DOI] [PubMed] [Google Scholar]
  192. Schwabe M., Zhao J., Kung H. F. Differential expression and ligand-induced modulation of the human interleukin-6 receptor on interleukin-6-responsive cells. J Biol Chem. 1994 Mar 11;269(10):7201–7209. [PubMed] [Google Scholar]
  193. Sehgal P. B., Walther Z., Tamm I. Rapid enhancement of beta 2-interferon/B-cell differentiation factor BSF-2 gene expression in human fibroblasts by diacylglycerols and the calcium ionophore A23187. Proc Natl Acad Sci U S A. 1987 Jun;84(11):3663–3667. doi: 10.1073/pnas.84.11.3663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Sehgal P. B., Zilberstein A., Ruggieri R. M., May L. T., Ferguson-Smith A., Slate D. L., Revel M., Ruddle F. H. Human chromosome 7 carries the beta 2 interferon gene. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5219–5222. doi: 10.1073/pnas.83.14.5219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Shacter E., Arzadon G. K., Williams J. Elevation of interleukin-6 in response to a chronic inflammatory stimulus in mice: inhibition by indomethacin. Blood. 1992 Jul 1;80(1):194–202. [PubMed] [Google Scholar]
  196. Shenkin A., Fraser W. D., Series J., Winstanley F. P., McCartney A. C., Burns H. J., Van Damme J. The serum interleukin 6 response to elective surgery. Lymphokine Res. 1989 Summer;8(2):123–127. [PubMed] [Google Scholar]
  197. Simms H. H., D'Amico R. Polymorphonuclear leukocyte dysregulation during the systemic inflammatory response syndrome. Blood. 1994 Mar 1;83(5):1398–1407. [PubMed] [Google Scholar]
  198. Sipe J. D., Bartle L. M., Loose L. D. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response. J Immunol. 1992 Jan 15;148(2):480–484. [PubMed] [Google Scholar]
  199. Snyers L., Content J. Enhancement of IL-6 receptor beta chain (gp130) expression by IL-6, IL-1 and TNF in human epithelial cells. Biochem Biophys Res Commun. 1992 Jun 30;185(3):902–908. doi: 10.1016/0006-291x(92)91712-y. [DOI] [PubMed] [Google Scholar]
  200. Snyers L., Fontaine V., Content J. Modulation of interleukin-6 receptors in human cells. Ann N Y Acad Sci. 1989;557:388–395. doi: 10.1111/j.1749-6632.1989.tb24031.x. [DOI] [PubMed] [Google Scholar]
  201. Squadrito F., Altavilla D., Canale P., Ioculano M. P., Campo G. M., Ammendolia L., Squadrito G., Saitta A., Calapai G., Caputi A. P. Contribution of intercellular adhesion molecule 1 (ICAM-1) to the pathogenesis of splanchnic artery occlusion shock in the rat. Br J Pharmacol. 1994 Nov;113(3):912–916. doi: 10.1111/j.1476-5381.1994.tb17079.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Squier M. K., Sehnert A. J., Cohen J. J. Apoptosis in leukocytes. J Leukoc Biol. 1995 Jan;57(1):2–10. doi: 10.1002/jlb.57.1.2. [DOI] [PubMed] [Google Scholar]
  203. St John Sutton M. G., Mercier L. A., Giuliani E. R., Lie J. T. Atrial myxomas: a review of clinical experience in 40 patients. Mayo Clin Proc. 1980 Jun;55(6):371–376. [PubMed] [Google Scholar]
  204. Stahl N., Boulton T. G., Farruggella T., Ip N. Y., Davis S., Witthuhn B. A., Quelle F. W., Silvennoinen O., Barbieri G., Pellegrini S. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science. 1994 Jan 7;263(5143):92–95. doi: 10.1126/science.8272873. [DOI] [PubMed] [Google Scholar]
  205. Starnes H. F., Jr, Pearce M. K., Tewari A., Yim J. H., Zou J. C., Abrams J. S. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J Immunol. 1990 Dec 15;145(12):4185–4191. [PubMed] [Google Scholar]
  206. Steffen M., Reinecker H. C., Petersen J., Doehn C., Pflüger I., Voss A., Raedler A. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients. Clin Exp Immunol. 1993 Jan;91(1):30–36. doi: 10.1111/j.1365-2249.1993.tb03349.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Steinberg K. P., Milberg J. A., Martin T. R., Maunder R. J., Cockrill B. A., Hudson L. D. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med. 1994 Jul;150(1):113–122. doi: 10.1164/ajrccm.150.1.8025736. [DOI] [PubMed] [Google Scholar]
  208. Strassmann G., Fong M., Kenney J. S., Jacob C. O. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest. 1992 May;89(5):1681–1684. doi: 10.1172/JCI115767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Strassmann G., Fong M., Windsor S., Neta R. The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine. 1993 Jul;5(4):285–290. doi: 10.1016/1043-4666(93)90058-d. [DOI] [PubMed] [Google Scholar]
  210. Svoboda P., Kantorová I., Ochmann J. Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma. 1994 Mar;36(3):336–340. doi: 10.1097/00005373-199403000-00009. [DOI] [PubMed] [Google Scholar]
  211. Szabo G., Kodys K., Miller-Graziano C. L. Elevated monocyte interleukin-6 (IL-6) production in immunosppressed trauma patients. II. Downregulation by IL-4. J Clin Immunol. 1991 Nov;11(6):336–344. doi: 10.1007/BF00918799. [DOI] [PubMed] [Google Scholar]
  212. Szabo G., Kodys K., Miller-Graziano C. L. Elevated monocyte interleukin-6 (IL-6) production in immunosuppressed trauma patients. I. Role of Fc gamma RI cross-linking stimulation. J Clin Immunol. 1991 Nov;11(6):326–335. doi: 10.1007/BF00918798. [DOI] [PubMed] [Google Scholar]
  213. Tabibzadeh S. S., Santhanam U., Sehgal P. B., May L. T. Cytokine-induced production of IFN-beta 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17 beta. J Immunol. 1989 May 1;142(9):3134–3139. [PubMed] [Google Scholar]
  214. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 1989 Aug 11;58(3):573–581. doi: 10.1016/0092-8674(89)90438-8. [DOI] [PubMed] [Google Scholar]
  215. Tate R. M., Repine J. E. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis. 1983 Sep;128(3):552–559. doi: 10.1164/arrd.1983.128.3.552. [DOI] [PubMed] [Google Scholar]
  216. Terebuh P. D., Otterness I. G., Strieter R. M., Lincoln P. M., Danforth J. M., Kunkel S. L., Chensue S. W. Biologic and immunohistochemical analysis of interleukin-6 expression in vivo. Constitutive and induced expression in murine polymorphonuclear and mononuclear phagocytes. Am J Pathol. 1992 Mar;140(3):649–657. [PMC free article] [PubMed] [Google Scholar]
  217. Thivierge M., Rola-Pleszczynski M. Platelet-activating factor enhances interleukin-6 production by alveolar macrophages. J Allergy Clin Immunol. 1992 Nov;90(5):796–802. doi: 10.1016/0091-6749(92)90104-a. [DOI] [PubMed] [Google Scholar]
  218. Tilg H., Trehu E., Atkins M. B., Dinarello C. A., Mier J. W. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 1994 Jan 1;83(1):113–118. [PubMed] [Google Scholar]
  219. Tovey M. G., Content J., Gresser I., Gugenheim J., Blanchard B., Guymarho J., Poupart P., Gigou M., Shaw A., Fiers W. Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals. J Immunol. 1988 Nov 1;141(9):3106–3110. [PubMed] [Google Scholar]
  220. Tsukada K., Katoh H., Shiojima M., Suzuki T., Takenoshita S., Nagamachi Y. Concentrations of cytokines in peritoneal fluid after abdominal surgery. Eur J Surg. 1993 Sep;159(9):475–479. [PubMed] [Google Scholar]
  221. Ueo H., Honda M., Adachi M., Inoue H., Nakashima H., Arinaga S., Akiyoshi T. Minimal increase in serum interleukin-6 levels during laparoscopic cholecystectomy. Am J Surg. 1994 Oct;168(4):358–360. doi: 10.1016/s0002-9610(05)80166-7. [DOI] [PubMed] [Google Scholar]
  222. Ueo H., Inoue H., Honda M., Uchida I., Nishimura M., Arinaga S., Nakashima H., Akiyoshi T. Production of interleukin-6 at operative wound sites in surgical patients. J Am Coll Surg. 1994 Sep;179(3):326–332. [PubMed] [Google Scholar]
  223. Ueyama M., Maruyama I., Osame M., Sawada Y. Marked increase in plasma interleukin-6 in burn patients. J Lab Clin Med. 1992 Nov;120(5):693–698. [PubMed] [Google Scholar]
  224. Ulich T. R., Yin S., Guo K., Yi E. S., Remick D., del Castillo J. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol. 1991 May;138(5):1097–1101. [PMC free article] [PubMed] [Google Scholar]
  225. Van Damme J., Opdenakker G., Simpson R. J., Rubira M. R., Cayphas S., Vink A., Billiau A., Van Snick J. Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med. 1987 Mar 1;165(3):914–919. doi: 10.1084/jem.165.3.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. Van Oers M. H., Van der Heyden A. A., Aarden L. A. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol. 1988 Feb;71(2):314–319. [PMC free article] [PubMed] [Google Scholar]
  227. Van Snick J., Cayphas S., Vink A., Uyttenhove C., Coulie P. G., Rubira M. R., Simpson R. J. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9679–9683. doi: 10.1073/pnas.83.24.9679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Waage A., Kaufmann C., Espevik T., Husby G. Interleukin-6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol. 1989 Mar;50(3):394–398. doi: 10.1016/0090-1229(89)90146-3. [DOI] [PubMed] [Google Scholar]
  229. Waage A., Slupphaug G., Shalaby R. Glucocorticoids inhibit the production of IL6 from monocytes, endothelial cells and fibroblasts. Eur J Immunol. 1990 Nov;20(11):2439–2443. doi: 10.1002/eji.1830201112. [DOI] [PubMed] [Google Scholar]
  230. Wang P., Ba Z. F., Morrison M. H., Ayala A., Dean R. E., Chaudry I. H. Mechanism of the beneficial effects of ATP-MgCl2 following trauma-hemorrhage and resuscitation: downregulation of inflammatory cytokine (TNF, IL-6) release. J Surg Res. 1992 Apr;52(4):364–371. doi: 10.1016/0022-4804(92)90117-i. [DOI] [PubMed] [Google Scholar]
  231. Wegenka U. M., Buschmann J., Lütticken C., Heinrich P. C., Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol. 1993 Jan;13(1):276–288. doi: 10.1128/mcb.13.1.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Weiland J. E., Davis W. B., Holter J. F., Mohammed J. R., Dorinsky P. M., Gadek J. E. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis. 1986 Feb;133(2):218–225. doi: 10.1164/arrd.1986.133.2.218. [DOI] [PubMed] [Google Scholar]
  233. Weissenbach J., Chernajovsky Y., Zeevi M., Shulman L., Soreq H., Nir U., Wallach D., Perricaudet M., Tiollais P., Revel M. Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7152–7156. doi: 10.1073/pnas.77.12.7152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Windsor A. C., Mullen P. G., Fowler A. A., Sugerman H. J. Role of the neutrophil in adult respiratory distress syndrome. Br J Surg. 1993 Jan;80(1):10–17. doi: 10.1002/bjs.1800800106. [DOI] [PubMed] [Google Scholar]
  235. Wong G. G., Witek-Giannotti J. S., Temple P. A., Kriz R., Ferenz C., Hewick R. M., Clark S. C., Ikebuchi K., Ogawa M. Stimulation of murine hemopoietic colony formation by human IL-6. J Immunol. 1988 May 1;140(9):3040–3044. [PubMed] [Google Scholar]
  236. Wood J. J., Grbic J. T., Rodrick M. L., Jordan A., Mannick J. A. Suppression of interleukin 2 production in an animal model of thermal injury is related to prostaglandin synthesis. Arch Surg. 1987 Feb;122(2):179–184. doi: 10.1001/archsurg.1987.01400140061007. [DOI] [PubMed] [Google Scholar]
  237. Wortel C. H., Doerschuk C. M. Neutrophils and neutrophil-endothelial cell adhesion in adult respiratory distress syndrome. New Horiz. 1993 Nov;1(4):631–637. [PubMed] [Google Scholar]
  238. Wortel C. H., van Deventer S. J., Aarden L. A., Lygidakis N. J., Büller H. R., Hoek F. J., Horikx J., ten Cate J. W. Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery. 1993 Sep;114(3):564–570. [PubMed] [Google Scholar]
  239. Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science. 1988 Aug 12;241(4867):825–828. doi: 10.1126/science.3136546. [DOI] [PubMed] [Google Scholar]
  240. Yasukawa K., Hirano T., Watanabe Y., Muratani K., Matsuda T., Nakai S., Kishimoto T. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J. 1987 Oct;6(10):2939–2945. doi: 10.1002/j.1460-2075.1987.tb02598.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  241. Yin T., Taga T., Tsang M. L., Yasukawa K., Kishimoto T., Yang Y. C. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J Immunol. 1993 Sep 1;151(5):2555–2561. [PubMed] [Google Scholar]
  242. Youker K., Smith C. W., Anderson D. C., Miller D., Michael L. H., Rossen R. D., Entman M. L. Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest. 1992 Feb;89(2):602–609. doi: 10.1172/JCI115626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  243. Yuan J., Wegenka U. M., Lütticken C., Buschmann J., Decker T., Schindler C., Heinrich P. C., Horn F. The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Mol Cell Biol. 1994 Mar;14(3):1657–1668. doi: 10.1128/mcb.14.3.1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Zhang X. G., Klein B., Bataille R. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood. 1989 Jul;74(1):11–13. [PubMed] [Google Scholar]
  245. Zhang Y., Lin J. X., Vilcek J. Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem. 1988 May 5;263(13):6177–6182. [PubMed] [Google Scholar]
  246. Zhong Z., Wen Z., Darnell J. E., Jr Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994 Apr 1;264(5155):95–98. doi: 10.1126/science.8140422. [DOI] [PubMed] [Google Scholar]
  247. Zhou D. H., Munster A. M., Winchurch R. A. Inhibitory effects of interleukin 6 on immunity. Possible implications in burn patients. Arch Surg. 1992 Jan;127(1):65–69. doi: 10.1001/archsurg.1992.01420010079011. [DOI] [PubMed] [Google Scholar]
  248. Zilberstein A., Ruggieri R., Korn J. H., Revel M. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J. 1986 Oct;5(10):2529–2537. doi: 10.1002/j.1460-2075.1986.tb04531.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  249. Zohlnhöfer D., Graeve L., Rose-John S., Schooltink H., Dittrich E., Heinrich P. C. The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand. FEBS Lett. 1992 Jul 20;306(2-3):219–222. doi: 10.1016/0014-5793(92)81004-6. [DOI] [PubMed] [Google Scholar]
  250. de Bandt J. P., Chollet-Martin S., Hernvann A., Lioret N., du Roure L. D., Lim S. K., Vaubourdolle M., Guechot J., Saizy R., Giboudeau J. Cytokine response to burn injury: relationship with protein metabolism. J Trauma. 1994 May;36(5):624–628. doi: 10.1097/00005373-199405000-00004. [DOI] [PubMed] [Google Scholar]
  251. de Waal Malefyt R., Abrams J., Bennett B., Figdor C. G., de Vries J. E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991 Nov 1;174(5):1209–1220. doi: 10.1084/jem.174.5.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES